Moolec Science (MLECW) Depreciation and Depletion (2023 - 2024)
Moolec Science (MLECW) posted Depreciation and Depletion of -$5032.0 for Q3 2024, down 100.09% sequentially from $5.8 million in Q2 2024, and down 150.86% YoY from $9894.0 in Q4 2023.
Moolec Science (MLECW) Depreciation and Depletion (2023 - 2024) Analysis & Trends
Moolec Science has reported Depreciation and Depletion for 2 years, with the latest figure at -$5032.0 in Q3 2024.
- Quarterly Depreciation and Depletion fell 150.86% year-over-year to -$5032.0 in Q3 2024, while the trailing twelve-month figure through Sep 2024 was $5.8 million (changed N/A YoY) and the FY2025 annual result came in at $6.0 million, up 3.72% from the prior year.
- Depreciation and Depletion eased to -$5032.0 in Q3 2024 per MLECW's latest filing, from $5.8 million in the prior quarter.
- Over five years, Depreciation and Depletion peaked at $5.8 million in Q2 2024 and troughed at -$6646.0 in Q1 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Moolec Science | 8,617.72 | -1.19 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 50,804.00 |
| Dec 31, 2024 | 50,804.00 |
| Sep 30, 2024 | -5,032.00 |
| Sep 30, 2024 | -5,032.00 |
| Jun 30, 2024 | 5.81 Mn |
| Jun 30, 2024 | 5.81 Mn |
| Mar 31, 2024 | -6,646.00 |
| Mar 31, 2024 | -6,646.00 |
| Dec 31, 2023 | -2,230.00 |
| Dec 31, 2023 | -2,230.00 |
| Sep 30, 2023 | 9,894.00 |
| Sep 30, 2023 | 9,894.00 |
| Jun 30, 2023 | 4.94 Mn |
| Jun 30, 2023 | 4.94 Mn |
| Mar 31, 2023 | 425.00 |
| Mar 31, 2023 | 425.00 |